Youngevity Announces Successful Completion of Pilot Study

SAN DIEGO--Youngevity International, Inc., a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announced today the successful completion of its pilot study conducted at the Richardson Center for Functional Foods and Nutraceuticals ("RCFFN") at the University of Manitoba.

"The Youngevity research protocols are comprehensive and rigorous. We are very pleased that the initial pilot program was a success and brings us confidence that the larger scale study should run smoothly and provide promising results." The RCFFN is one of the most advanced bioprocessing and product development facilities in Canada and around the world. The RCFFN has focused on value-added foods, food bioactives, and nutraceuticals that offer health promotion, performance enhancement, and disease prevention and management since 2006.

The pilot study was performed as the initial phase to the comprehensive and detailed study the RCFFN is conducting on the signature "90 For Life" Youngevity product set and their effects on various health biomarkers, which include those for weight management, inflammation, and blood sugar issues. The Ethics Committee at the University of Manitoba reviewed and approved the Youngevity products and their dosage levels in the rigorous protocols that will be used for the study. It was deemed that the Youngevity products chosen were highly tolerable and well within the range of the confidence levels to initiate the comprehensive study.

Dr. Ramprasath Vanu Ramkumar, Adjunct Professor and Research Associate for the Department of Human Nutritional Sciences at RCFFN, said, "The Youngevity research protocols are comprehensive and rigorous. We are very pleased that the initial pilot program was a success and brings us confidence that the larger scale study should run smoothly and provide promising results."

"The successful completion of the pilot study is another milestone for Youngevity, and we expect the research will be completed by the first quarter of 2014 and will be reported within the same time frame," said Steve Wallach, Youngevity's Chief Executive Officer. "This is Youngevity's second large scale research study performed by a recognized academic research institution to provide the best analysis of these signature Youngevity products. In the past year, the Nutraceutical Research Institute at Clemson University directed a research study demonstrating the safety, inflammatory benefits, and effect on various human cancer cells lines of the Youngevity products, Beyond Tangy Tangerine® and Ultimate Classic Plant Derived Minerals."

 

More Youngevity News and Articles

 

Youngevity Profile

Create a Free Youngevity Rep Listing